Mimedx (MDXG) EV to EBITDA (2011 - 2026)

Mimedx has disclosed EV to EBITDA across 16 years of filings, most recently posting 23.03 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 136.29% year-over-year to 23.03; the TTM figure through Jun 2026 stood at 48.58 (up 165.13% YoY), while the FY2025 annual figure was 13.09, down 41.12% from the prior year.
• EV to EBITDA came in at 23.03 for Q2 2026 at Mimedx, up from 26.7 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 123.06 in Q1 2025 to a low of 977.13 in Q1 2023.
• Average EV to EBITDA over 5 years is 19.12, with a median of 40.3 recorded in 2024.
• The largest YoY upside for EV to EBITDA was 314.08% in 2023 against a maximum downside of 1883.21% in 2023.
• Over 5 years, EV to EBITDA stood at 22.12 in 2022, then surged by 174.3% to 60.66 in 2023, then soared by 95.22% to 118.43 in 2024, then sank by 66.49% to 39.69 in 2025, then plunged by 158.02% to 23.03 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 23.03 in Q2 2026, 26.7 in Q1 2026, and 39.69 in Q4 2025.